RxDoctor Payments Data

Shivani Patel, MD

Dermatology · Lutherville, MDNPI 1891176244

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $67,347 of the $98,328 with a category attached, or 68.5%. 29 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 54.7% of the total. Reporting peaked in 2023 at $37,669 and has fallen 96.7% since, to $1,225 in 2025. Among dermatology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$98,328in general payments, 2019–2025

Across 422 payments — averaging $233.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$54K
  • Sanofi$18K
  • Incyte Corporation$8K
  • Amgen$5K
  • Arcutis Biotherapeutics, Inc.$4K
  • Pfizer$3K
  • plus $8K from 23 others

What the payments were for

  • Consulting fees$15,06915%
  • Speaking & faculty fees$67,34768%
  • Travel & lodging$6,0676%
  • Food & beverage$9,57410%
  • Education$2720%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$98,328 in reported general payments places this provider in the 90th percentile of 306 dermatology providers in Maryland.

See all dermatology providers in Maryland

Medicare billing

Part B allowed, 2024
$127,848
Medicare patients
433
Services billed
1,929

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab19$71,677
Dupixent SyringeDupilumab13$48,646
Fluocinonide24$1,856
Triamcinolone Acetonide67$836
Desonide14$827
Clobetasol Propionate18$824
Ketoconazole48$801
Fluorouracil11$788
Doxycycline Hyclate19$380
Clindamycin Phosphate15$323
Mupirocin24$161
Hydrocortisone11$35

Paid to pharmacies, not to this prescriber.

Other dermatology in Lutherville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →